Structure Therapeutics Inc. (GPCR) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Structure Therapeutics In...

    NASDAQ: GPCR · Real-Time Price · USD
    21.20
    0.29 (1.39%)
    At close: Sep 15, 2025, 11:42 AM

    Structure Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -122.53M -89.62M -51.32M -38.05M
    Depreciation & Amortization
    		 992K 295K 277K 266.35K
    Stock-Based Compensation
    		 18.79M 8.19M 2.51M 1.49M
    Other Working Capital
    		 -343K 7.83M 815K 2.17M
    Other Non-Cash Items
    		 -16.86M -5.32M -558K 32.2M
    Deferred Income Tax
    		 n/a n/a n/a 27.00
    Change in Working Capital
    		 2.96M 6.97M 2.97M 4.06M
    Operating Cash Flow
    		 -116.64M -79.49M -46.12M -32.16K
    Capital Expenditures
    		 -1.29M -2.17M -155K -1.21K
    Cash Acquisitions
    		 n/a n/a 61.95K -19.07K
    Purchase of Investments
    		 -702.52M -416.99M -123.45M -4.21K
    Sales Maturities Of Investments
    		 344.9M 151.05M 61.5M 23.28K
    Other Investing Acitivies
    		 n/a -231.38K -61.95K 19.07K
    Investing Cash Flow
    		 -358.91M -268.34M -62.11M 17.86K
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a -6K n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 690K -20.77M -2.48M -103.25M
    Financial Cash Flow
    		 515.26M 451.53M 29.01M 103.25K
    Net Cash Flow
    		 39.72M 103.7M -79.21M 88.95K
    Free Cash Flow
    		 -117.93M -81.66M -46.27M -33.37K

    Add to Watchlist